<DOC>
	<DOCNO>NCT01706874</DOCNO>
	<brief_summary>The purpose study assess impact intervention ( scale every 06 month associate use mouthwash essential oil ( toothpaste Listerine速 2 time / day contain polymer Triclosan ( Colgate Total速 ) ) activity rheumatoid arthritis</brief_summary>
	<brief_title>Effect Assessment Periodontal Prophylaxis Rheumatoid Arthritis Activity .</brief_title>
	<detailed_description>Introduction : Several epidemiological study suggest link periodontal disease rheumatoid arthritis . In cohort , risk development rheumatoid arthritis increase subject periodontal disease . The main bacterium implicate chronic periodontal disease Porphyromas gingivalis , commensal microorganism mouth . P. gingivalis microorganism deiminase capable transform arginine citrulline , suspect play major role production anti-citrulline antibody , principal diagnostic marker rheumatoid arthritis . Hypotheses : The regular professional individual plaque control patient rheumatoid arthritis ( standard care ) - i.e . decrease oral bacterial load , include P. gingivalis - reduces activity rheumatoid arthritis Principal objective : To assess impact professional periodontal scale every 6 month combine individual plaque control , i.e . toothbrushing plus use mouthrinses rheumatoid arthritis activity . Methodology : The trial design innovative base random selection sample patient observational cohort patient describe recent publication `` Cohort Multiple Randomised Controlled Trials Design '' ( Ref . : BMJ 2010 ; 340 : c1066 ) . A randomly select sample eligible patient cohort ask take part study . Changes randomise sample compare potentially eligible patient cohort . The cohort use ESPOIR cohort , cohort include 813 patient initially present early undifferentiated polyarthritis develop rheumatoid arthritis anti-citrulline antibody approximately 40 50 % case . Procedures study : Periodontal scaling every 6 month twice daily use mouthwash contain essential oil ( Listerine速 ) plus triclosan/copolymer toothpaste ( Colgate Total速 ) . Sample size calculation : The principal assessment criterion DAS variation 1 year . The expected statistical power 80 % ( type I risk set 5 % ) standard deviation common two sample DAS variation evaluate 1.5 . With hypothesis , inclusion 100 patient study group 100 patient control group produce effect size 0.40 ( i.e . difference DAS two group equal 0.6 ) . Statistical analysis : A linear , mixed-effects model use compare DAS variation two group . In addition , Mixed Model Repeated Measurements ( MMRM ) base linear mixed model include two random effect , i.e . : centre effect centre*treatment interaction effect , use measure heterogeneity centre heterogeneity effect procedure . Finally , propensity score adjustment weight use take account potential imbalance two study arm .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Patients rheumatoid arthritis accord EULAR criterion / ACR 2010 10 year evolution Patients include ESPOIR cohort Patients DAS28 &gt; 3.2 AntiCCP positive negative Age : 18 year old 80 year Affiliated social security Refusal participate study DAS28 &lt; 3.2 Patient guardianship Participation another protocol without agreement dentist Not affiliate social security</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>P.gingivalis</keyword>
	<keyword>Periodontal disease</keyword>
	<keyword>Plaque control</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Oral hygiene instruction</keyword>
</DOC>